Position in HIMS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,142,616
+$3,705,034 QoQ
Shares Held
263,704
+0.7% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 507 holders
Holding Since
Dec 2020
18 quarters on record
Voting authority
Sole 0%
Shared 93%
None 7%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Derivatives in HIMS
reported options exposure · as of Sep 30, 2025CallValue
$0
CallShares
0
PutValue
$39,704,000
PutShares
700,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $802,494,373 across 36 Drug Manufacturers - Specialty & Generic names. HIMS ranks #13 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
18,815,747 | $298,794,060 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
502,267 | $84,652,078 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
619,298 | $68,704,917 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
123,215 | $66,761,581 | |
| 5 | ZTS |
Zoetis Inc.
|
812,181 | $58,363,324 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,396,427 | $34,366,066 | |
| 7 | ALKS |
Alkermes plc.
|
630,325 | $33,029,029 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,581,869 | $27,382,151 |
All Filings in HIMS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,142,616 | 263,704 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,437,582 | 261,926 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,467,539 | 568,757 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $39,704,000 | 700,000 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $35,231,399 | 621,146 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $30,744,836 | 616,747 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $16,848,551 | 570,171 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $8,438,820 | 349,000 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $31,130,636 | 1,287,454 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $30,617,133 | 1,662,168 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,375,484 | 167,186 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,846,726 | 184,016 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $2,057,905 | 327,171 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $12,425,897 | 1,321,904 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,246,608 | 528,892 | Shares | Defined | 2023-05-22 | |
| 2021-12-31 | $12,708,932 | 1,940,295 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $14,738,294 | 1,954,681 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $21,185,317 | 1,945,392 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $25,259,642 | 1,909,270 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||